Post by MikeTesteron Jan 24, 2025 2:06am
51 Views
Post# 36418400
Unity Biotechnology (UBX): A Pioneering Approach to Slow, Ha
Unity Biotechnology (UBX): A Pioneering Approach to Slow, HaLooks like UBX is making some serious moves in the senolytic space. Phase 2 BEHOLD study results are impressive - single injection showing statistically significant visual acuity improvements. Cash runway into Q3 2025 gives them breathing room. Watching closely for ASPIRE study data in Q1 2025. Could be a game changer for DME treatment.Grabbed some shares on the dip. Management seems focused on optimizing resources with headcount reductions. Ophthalmology pipeline looking solid with nAMD and DME programs. Might add more if we see strong ASPIRE results.BTW, BeyondSPX has high quality in-depth analysis on just about every US stock out there, even microcaps, for free. Great resource for digging into companies like Unity. https://beyondspx.com/article/unity-biotechnology-ubx-a-pioneering-approach-to-slow-halt-and-reverse-diseases-of-aging